Body Revival® was evaluated in a pilot clinical observation study for its supportive role in patients suffering from Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD), a growing liver disorder commonly associated with obesity, diabetes, high cholesterol, and metabolic imbalance. The study was conducted at J. B. Roy State Ayurvedic Medical College & Hospital between September 2024 and April 2025.

A total of 15 patients with Grade I to Grade III fatty liver participated in the study after informed consent. Patients received Body Revival® therapy for 8 weeks along with regular monitoring through ultrasound (USG), liver function tests, blood glucose, cholesterol levels, and other clinical parameters.

The study findings showed encouraging improvements in liver health and overall wellness. After completion of therapy:

• 10 out of 15 patients showed normal liver findings on ultrasound (USG)
• Remaining patients demonstrated noticeable reduction in fatty liver severity
• Liver enzymes including AST, ALT, ALP, and GGT improved significantly
• Many patients experienced better digestion, improved appetite, increased stamina, and reduced abdominal discomfort
• Improvements were also observed in cholesterol levels, blood sugar balance, bilirubin levels, and metabolic health markers in several cases

Body Revival® contains a blend of Ayurvedic herbal ingredients traditionally known for their antioxidant, anti-inflammatory, hepatoprotective, and metabolic-supportive properties. The formulation is designed to support liver function, assist detoxification, and help improve overall quality of life.

The pilot study concluded that Body Revival® demonstrated promising supportive benefits in managing MAFLD and chronic liver health concerns. Researchers also noted the need for larger clinical studies to further evaluate its long-term therapeutic potential.